"Immunization, Passive" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER).
| Descriptor ID |
D007116
|
| MeSH Number(s) |
E02.095.465.425.400.330 E05.478.550.520
|
| Concept/Terms |
Immunization, Passive- Immunization, Passive
- Immunizations, Passive
- Passive Immunization
- Passive Immunizations
Passive Antibody Transfer- Passive Antibody Transfer
- Antibody Transfer, Passive
- Antibody Transfers, Passive
- Passive Antibody Transfers
- Transfer, Passive Antibody
- Transfers, Passive Antibody
- Passive Transfer of Immunity
Immunotherapy, Passive- Immunotherapy, Passive
- Passive Immunotherapy
- Immunotherapies, Passive
- Passive Immunotherapies
Immunoglobulin Therapy- Immunoglobulin Therapy
- Therapy, Immunoglobulin
- Immunoglobulin Therapies
- Therapies, Immunoglobulin
|
Below are MeSH descriptors whose meaning is more general than "Immunization, Passive".
Below are MeSH descriptors whose meaning is more specific than "Immunization, Passive".
This graph shows the total number of publications written about "Immunization, Passive" by people in this website by year, and whether "Immunization, Passive" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2022 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunization, Passive" by people in Profiles.
-
Recent advances in passive immunotherapies for COVID-19: The Evidence-Based approaches and clinical trials. Int Immunopharmacol. 2022 Aug; 109:108786.
-
Clinical update on COVID-19 for the emergency and critical care clinician: Medical management. Am J Emerg Med. 2022 Jun; 56:158-170.
-
Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update. Crit Care Med. 2021 03 01; 49(3):e219-e234.
-
Narrative review: tetanus-a health threat after natural disasters in developing countries. Ann Intern Med. 2011 Mar 01; 154(5):329-35.
-
Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages. FASEB J. 2008 Nov; 22(11):4022-32.
-
A concise update on the status of liver transplantation for hepatitis B virus: the challenges in 2002. Liver Transpl. 2002 Jan; 8(1):2-9.
-
A proteoglycan (aggrecan)-specific T cell hybridoma induces arthritis in BALB/c mice. J Immunol. 1995 Sep 01; 155(5):2679-87.
-
Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis. Nat Med. 1995 Jun; 1(6):558-63.
-
IVIg for GBS: potential problems in the alphabet soup. Neurology. 1993 May; 43(5):857-8.
-
Intravenous immune globulin for passive tetanus prophylaxis. J Infect Dis. 1993 Feb; 167(2):498-9.